Overview

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

Status:
Completed
Trial end date:
2006-03-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the long-term safety and tolerability of SPD476 in the maintenance of ulcerative colitis remission.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Mesalamine